Latest filing published 01 Dec 2023 for Greenhill & Co INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Kevin Ferro across 2 companies, led by Greenhill & Co Inc and KOS Pharmaceuticals Inc. Over a trading history stretching from 27 April 2006 to 30 November 2023, the count stands at 19 filings.
On the market, this insider has only ever bought: 6 purchases, €729k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 10 share grants.
The median purchase comes to €100k. 2 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 1 December 2023: a transaction, in Greenhill & Co Inc. The last insider purchase was made public on 4 May 2022, 1,634 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations